AstraZeneca Fights Damages In Drug Pricing Suit
By Erin Marie Daly · August 7, 2007, 12:00 AM EDT
On the heels of a similar bid by Warrick Pharmaceuticals Corp., AstraZeneca Pharmaceuticals LP has rejected a request that it shell out treble damages to two classes in the average wholesale...
To view the full article, register now.